Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study
- Author
- HUOBER, Jens1 2 ; VON MINCKWITZ, Gunter3 ; HÖGEL, Bernhard12 ; DARB-ESFAHANI, Silvia4 ; MEHTA, Keyur3 ; LOIBL, Sibylle3 ; DENKERT, Carsten4 ; TESCH, Hans5 ; WEISS, Erich6 ; ZAHM, Dirk Michael7 ; BELAU, Antje8 ; KHANDAN, Fariba9 ; HAUSCHILD, Maik10 ; THOMSSEN, Christoph11
[1] Brustzentrum Kantonsspital St. Gallen, St. Gallen, Switzerland
[2] Department of Gynaecology, University Tiibingen, Tiibingen, Germany
[3] German Breast Group, Martin-Behaim Str. 12, 63263 Neu-Isenburg, Germany
[4] Charité, Institute of Pathology, Translational Tumorpathology Unit, Berlin, Germany
[5] Onkologische Gemeinschaftspraxis am Bethanien Krankenhaus, Frankfurt am Main, Germany
[6] Hospital Sindelfingen-Böblingen, Böblingen, Germany
[7] SRH Waldkliniken, Gera, Germany
[8] Department of Gynaecology, University Greifswald, Greifswald, Germany
[9] St. Markus Hospital, Frankfurt am Main, Germany
[10] Hospital Rheinfelden, Rheinfelden, Germany
[11] Department of Gynaecology, Martin Luther University, Halle, Germany
[12] Frauenklinik vom Roten Kreuz, München, Germany - Source
Breast cancer research and treatment. 2010, Vol 124, Num 1, pp 133-140, 8 p ; ref : 22 ref
- CODEN
- BCTRD6
- ISSN
- 0167-6806
- Scientific domain
- Medical oncology; Obstetrics, gynecology, andrology; Pharmacology drugs
- Publisher
- Springer, Dordrecht
- Publication country
- Netherlands
- Document type
- Article
- Language
- English
- Author keyword
- Age Breast cancer Lobular histology Neoadjuvant chemotherapy Predictive factors
- Keyword (fr)
- Age Anthracyclines Anticancéreux Cancer du sein Chimiothérapie Cyclophosphamide Docétaxel Doxorubicine Dérivé du taxane Facteur prédictif Histologie Médicament Phénotype Traitement néoadjuvant Agent alkylant Antimitotique Cancer DNA topoisomerase (ATP-hydrolysing) Dérivé de l'oxazaphosphinane Enzyme Inhibiteur de la topoisomérase II Inhibiteur enzyme Isomerases Moutarde à l'azote Pathologie de la glande mammaire Pathologie du sein Traitement Tumeur maligne
- Keyword (en)
- Age Anthracyclins Antineoplastic agent Breast cancer Chemotherapy Cyclophosphamide Docetaxel Doxorubicin Taxane derivatives Predictive factor Histology Drug Phenotype Neoadjuvant treatment Alkylating agent Antimitotic Cancer DNA topoisomerase (ATP-hydrolysing) Oxazaphosphinane derivatives Enzyme Topoisomerase II inhibitor Enzyme inhibitor Isomerases Nitrogen mustard Mammary gland diseases Breast disease Treatment Malignant tumor
- Keyword (es)
- Edad Antraciclinas Anticanceroso Cáncer del pecho Quimioterapia Ciclofosfamida Docetaxel Doxorubicina Taxane derivado Factor predictivo Histología Medicamento Fenotipo Neocoadyuvante tratamiento Agente alquilante Antimitótico Cáncer DNA topoisomerase (ATP-hydrolysing) Oxazafosfinano derivado Enzima Inhibidor topoisomerase II Inhibidor enzima Isomerases Mostaza al nitrógeno Glándula mamaria patología Seno patología Tratamiento Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20E Mammary gland diseases / 002B20E02 Tumors
- Discipline
- Gynecology. Andrology. Obstetrics
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 23309233
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1007/s10549-010-1103-9 
https://dx.doi.org/10.1007/s10549-010-1103-9
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-010-1103-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Breast cancer research and treatment\";s:9:\"\u0000*\u0000stitle\";s:24:\"Breast cancer res. treat\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"124\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"133\";s:8:\"\u0000*\u0000epage\";s:3:\"140\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0167-6806\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"HUOBER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Jens\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:21:\"VON MINCKWITZ, Gunter\";i:1;s:16:\"H\u00d6GEL, Bernhard\";i:2;s:21:\"DARB-ESFAHANI, Silvia\";i:3;s:12:\"MEHTA, Keyur\";i:4;s:14:\"LOIBL, Sibylle\";i:5;s:16:\"DENKERT, Carsten\";i:6;s:11:\"TESCH, Hans\";i:7;s:12:\"WEISS, Erich\";i:8;s:18:\"ZAHM, Dirk Michael\";i:9;s:12:\"BELAU, Antje\";i:10;s:15:\"KHANDAN, Fariba\";i:11;s:15:\"HAUSCHILD, Maik\";i:12;s:19:\"THOMSSEN, Christoph\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCTRD6\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study\";s:8:\"\u0000*\u0000place\";s:9:\"Dordrecht\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-010-1103-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Breast cancer research and treatment\";s:9:\"\u0000*\u0000stitle\";s:24:\"Breast cancer res. treat\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"124\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"133\";s:8:\"\u0000*\u0000epage\";s:3:\"140\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0167-6806\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"HUOBER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Jens\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:21:\"VON MINCKWITZ, Gunter\";i:1;s:16:\"H\u00d6GEL, Bernhard\";i:2;s:21:\"DARB-ESFAHANI, Silvia\";i:3;s:12:\"MEHTA, Keyur\";i:4;s:14:\"LOIBL, Sibylle\";i:5;s:16:\"DENKERT, Carsten\";i:6;s:11:\"TESCH, Hans\";i:7;s:12:\"WEISS, Erich\";i:8;s:18:\"ZAHM, Dirk Michael\";i:9;s:12:\"BELAU, Antje\";i:10;s:15:\"KHANDAN, Fariba\";i:11;s:15:\"HAUSCHILD, Maik\";i:12;s:19:\"THOMSSEN, Christoph\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCTRD6\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study\";s:8:\"\u0000*\u0000place\";s:9:\"Dordrecht\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-010-1103-9\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-010-1103-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Breast cancer research and treatment\";s:9:\"\u0000*\u0000stitle\";s:24:\"Breast cancer res. treat\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"124\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"133\";s:8:\"\u0000*\u0000epage\";s:3:\"140\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0167-6806\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"HUOBER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Jens\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:21:\"VON MINCKWITZ, Gunter\";i:1;s:16:\"H\u00d6GEL, Bernhard\";i:2;s:21:\"DARB-ESFAHANI, Silvia\";i:3;s:12:\"MEHTA, Keyur\";i:4;s:14:\"LOIBL, Sibylle\";i:5;s:16:\"DENKERT, Carsten\";i:6;s:11:\"TESCH, Hans\";i:7;s:12:\"WEISS, Erich\";i:8;s:18:\"ZAHM, Dirk Michael\";i:9;s:12:\"BELAU, Antje\";i:10;s:15:\"KHANDAN, Fariba\";i:11;s:15:\"HAUSCHILD, Maik\";i:12;s:19:\"THOMSSEN, Christoph\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCTRD6\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study\";s:8:\"\u0000*\u0000place\";s:9:\"Dordrecht\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-010-1103-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Breast cancer research and treatment\";s:9:\"\u0000*\u0000stitle\";s:24:\"Breast cancer res. treat\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"124\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"133\";s:8:\"\u0000*\u0000epage\";s:3:\"140\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0167-6806\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"HUOBER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Jens\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:21:\"VON MINCKWITZ, Gunter\";i:1;s:16:\"H\u00d6GEL, Bernhard\";i:2;s:21:\"DARB-ESFAHANI, Silvia\";i:3;s:12:\"MEHTA, Keyur\";i:4;s:14:\"LOIBL, Sibylle\";i:5;s:16:\"DENKERT, Carsten\";i:6;s:11:\"TESCH, Hans\";i:7;s:12:\"WEISS, Erich\";i:8;s:18:\"ZAHM, Dirk Michael\";i:9;s:12:\"BELAU, Antje\";i:10;s:15:\"KHANDAN, Fariba\";i:11;s:15:\"HAUSCHILD, Maik\";i:12;s:19:\"THOMSSEN, Christoph\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCTRD6\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study\";s:8:\"\u0000*\u0000place\";s:9:\"Dordrecht\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1007\/s10549-010-1103-9\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study\";s:9:\"\u0000*\u0000jtitle\";s:36:\"Breast cancer research and treatment\";s:9:\"\u0000*\u0000stitle\";s:24:\"Breast cancer res. treat\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"124\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"133\";s:8:\"\u0000*\u0000epage\";s:3:\"140\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0167-6806\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"HUOBER\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Jens\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:21:\"VON MINCKWITZ, Gunter\";i:1;s:16:\"H\u00d6GEL, Bernhard\";i:2;s:21:\"DARB-ESFAHANI, Silvia\";i:3;s:12:\"MEHTA, Keyur\";i:4;s:14:\"LOIBL, Sibylle\";i:5;s:16:\"DENKERT, Carsten\";i:6;s:11:\"TESCH, Hans\";i:7;s:12:\"WEISS, Erich\";i:8;s:18:\"ZAHM, Dirk Michael\";i:9;s:12:\"BELAU, Antje\";i:10;s:15:\"KHANDAN, Fariba\";i:11;s:15:\"HAUSCHILD, Maik\";i:12;s:19:\"THOMSSEN, Christoph\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BCTRD6\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study\";s:8:\"\u0000*\u0000place\";s:9:\"Dordrecht\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
